Tumour-derived factors prime microglia for immune checkpoint-mediated T-cell regulation
- 1University of Cologne
Abstract
Tumour-associated microglia are major regulators of the immune microenvironment in brain malignancies, yet the early mechanisms by which tumour-derived signals shape their immune phenotype remain poorly understood. We used quantitative proteomic analysis on microglia upon tumour exposure and observed extensive remodelling of the microglial proteome following exposure to tumour-conditioned media, indicating that soluble mediators represent the dominant drivers of early microglial activation. Microglia reprogramming was characterized by coordinated upregulation of inflammatory mediators together with proteins involved in antigen presentation and T-cell regulation, including MHC-I, PD-L1 and Galectin-9. Flow cytometric validation using multiple murine and human cell models confirmed the increased expression of PD-L1 and MHC-I on microglia following exposure to tumour-derived conditioned media. Subsequently, tumour-conditioned microglia promoted expression of the inhibitory receptors PD-1 and TIM-3 on T-cells after coculture. Importantly, integration of publicly available single-cell RNA sequencing datasets and cell-cell communication analysis further demonstrated that this immune-regulatory program is recapitulated in microglia from patients with brain tumours. Together, our findings identify an early, soluble factor-driven microglial activation program that precedes direct tumour contact and integrates inflammatory activation with immune checkpoint regulation. These results provide a mechanistic framework for the early establishment of an immunosuppressive brain tumour microenvironment and highlight microglial immune checkpoint pathways as potential targets for therapeutic intervention.
Related
- Atractylenolide I ameliorates microglia-mediated cerebral ischemia/reperfusion injury by suppressing the TLR4/NF-κB/NLRP3 inflammasome axis
- Microglia-derived Small Extracellular Vesicles Promote Bone Marrow Monocyte Expansion and Recruitment in Glioblastoma.
- 418 B cell regulation of anti-PD-1 immune checkpoint inhibition
- Radiation therapy synergizes with mRNA vaccination to overcome microglia-mediated suppression of dendritic cell migration and T cell priming in glioblastoma
- An integrated human forebrain organoid reveals microglia-mediated CD8⁺ T cell recruitment and neuroimmune dysfunction in Alzheimer's disease pathology.
BibTeX
@misc{schreurs2026tumourderived,
title = {{Tumour-derived factors prime microglia for immune checkpoint-mediated T-cell regulation}},
author = {L. D. Schreurs and J. Barz and T.-H. Nguyen and J. Schmedding and L. Lobastova and P. Hoelker and T. Seeger-Nukpezah and J.-W. Lackmann and J. C. Hollenbeck and C. Ising and U. Kahlert and M. Timmer and R. Goldbrunner and V. Neuschmelting and P.-H. Nguyen},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.12.758469},
url = {https://www.biorxiv.org/content/10.64898/2026.10.12.758469v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - Tumour-derived factors prime microglia for immune checkpoint-mediated T-cell regulation
AU - L. D. Schreurs
AU - J. Barz
AU - T.-H. Nguyen
AU - J. Schmedding
AU - L. Lobastova
AU - P. Hoelker
AU - T. Seeger-Nukpezah
AU - J.-W. Lackmann
AU - J. C. Hollenbeck
AU - C. Ising
AU - U. Kahlert
AU - M. Timmer
AU - R. Goldbrunner
AU - V. Neuschmelting
AU - P.-H. Nguyen
PY - 2026
DA - 2026/10/12
PB - bioRxiv
DO - 10.64898/2026.10.12.758469
UR - https://www.biorxiv.org/content/10.64898/2026.10.12.758469v1
AB - Tumour-associated microglia are major regulators of the immune microenvironment in brain malignancies, yet the early mechanisms by which tumour-derived signals shape their immune phenotype remain poorly understood. We used quantitative proteomic analysis on microglia upon tumour exposure and observed extensive remodelling of the microglial proteome following exposure to tumour-conditioned media, indicating that soluble mediators represent the dominant drivers of early microglial activation. Microglia reprogramming was characterized by coordinated upregulation of inflammatory mediators together with proteins involved in antigen presentation and T-cell regulation, including MHC-I, PD-L1 and Galectin-9. Flow cytometric validation using multiple murine and human cell models confirmed the increased expression of PD-L1 and MHC-I on microglia following exposure to tumour-derived conditioned media. Subsequently, tumour-conditioned microglia promoted expression of the inhibitory receptors PD-1 and TIM-3 on T-cells after coculture. Importantly, integration of publicly available single-cell RNA sequencing datasets and cell-cell communication analysis further demonstrated that this immune-regulatory program is recapitulated in microglia from patients with brain tumours. Together, our findings identify an early, soluble factor-driven microglial activation program that precedes direct tumour contact and integrates inflammatory activation with immune checkpoint regulation. These results provide a mechanistic framework for the early establishment of an immunosuppressive brain tumour microenvironment and highlight microglial immune checkpoint pathways as potential targets for therapeutic intervention.
ER -